Skip to main content
SpringerLink
Log in

How do mutated oncogenes and tumor suppressor genes cause cancer?

  • Review
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

In recent decades we have been given insight into the process that transforms a normal cell into a malignant cancer cell. It has been recognised that malignant transformation occurs through successive mutations in specific cellular genes, leading to the activation of oncogenes and inactivation of tumor suppressor genes. The further study of these genes has generated much of its excitement from the convergence of experiments addressing the genetic basis of cancer, together with cellular pathways that normally control important cellular regulatory programmes. In the present review the context in which oncogenes such as proliferation, cell death/apoptosis, differentiation and senescence will be described, as well as how these cellular programmes become deregulated in cancer due to mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Palmero I, Peters G. Perturbation of cell cycle regulators in human cancer.Cancer Surv 1996;27: 351–367.

    CAS  PubMed  Google Scholar 

  2. Wyllie AH. Apoptosis and carcinogenesis.Eur J Cell Biol 1997;73: 189–197.

    CAS  PubMed  Google Scholar 

  3. Hayflick L. The limitedin vitro lifetime of human diploid strains.Exp Cell Res 1965;37: 614–636.

    Article  CAS  PubMed  Google Scholar 

  4. Campisi J. Replicative senescence: An old live's tale?.Cell 1996;84: 497–500.

    Article  CAS  PubMed  Google Scholar 

  5. Cleaver JE. It was a very good year for DNA repair.Cell 1994;76: 1–4.

    Article  CAS  PubMed  Google Scholar 

  6. Graña X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).Oncogene 1995;11: 211–219.

    PubMed  Google Scholar 

  7. Pardee AB. G-1 events and regulation of cell proliferation.Science 1989;246: 603–608.

    Article  CAS  PubMed  Google Scholar 

  8. Kamb A, Gruis NA, Weaver-Feldhaus J. A cell cycle regulator potentially involved in genesis of many tumor types.Science 1994;264: 436–440.

    Article  CAS  PubMed  Google Scholar 

  9. Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the BCL2 family and cell death,Blood 1996;88: 386–401.

    Article  CAS  PubMed  Google Scholar 

  10. Whyte M. ICE/CED-3 proteases in apoptosis.Cell Biol 1996;6: 245–248.

    CAS  Google Scholar 

  11. Fraser A, Evan G. A license to kill.Cell 1996;85: 781–784.

    Article  CAS  PubMed  Google Scholar 

  12. Vogelstein B, Kinzler KW. p53 function and dysfunction.Cell 1992;70: 523–526.

    Article  CAS  PubMed  Google Scholar 

  13. Olsson I, Bergh G, Ehinger M, Gullberg U. Cell differentiation in acute myeloid leukaemia.Eur J Hematol 1997;57: 1–16.

    Article  Google Scholar 

  14. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia.Nature 1978;274: 535.

    Article  CAS  PubMed  Google Scholar 

  15. Alcorta DA,et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.Proc Nat Acad Sci USA 1996;93: 13742–13747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer.Current Opinion in Genetics & Development 1995;5: 249–255.

    Article  CAS  Google Scholar 

  17. Jones JL, Walker RA. Cell-cell and cell-stromal interactions in breast cancer invasion and metastasis.International Journal of Oncology 1997;11: 609–616.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Laboratory of Radiumhemmet, CCK, Karolinska Hospital, S-171 76, Stockholm, Sweden

    Dan Grandér

Authors
  1. Dan Grandér
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grandér, D. How do mutated oncogenes and tumor suppressor genes cause cancer?. Med Oncol 15, 20–26 (1998). https://doi.org/10.1007/BF02787340

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02787340

Keywords

Search

Navigation